CIZEPNUE
DEAD

Serial Number

79301741

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CIZEPNUE Trademark

Serial Number: 79301741 • Registration: 6392106

CIZEPNUE is a trademark filed by NOVARTIS AG on November 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 16, 2020

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Cancellation Date

February 6, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 21, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 21, 2025 DETH
NOTIFICATION PROCESSED BY IB
Aug 28, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 9, 2021 FICS
FINAL DISPOSITION PROCESSED
Aug 9, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 22, 2021 GPAR
TEAS SECTION 7 REQUEST RECEIVED
Jul 6, 2021 ES7R
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 5, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2021 CNSA
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 3, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 14, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 7, 2021 REPR